Position in AZN
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$16,061,003
+$340,597 QoQ
Shares Held
84,701
+6.3% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#253
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cullen/Frost Bankers, Inc. holds $397,272,361 across 15 Drug Manufacturers - General names. AZN ranks #7 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
101,158 | $121,331,950 | |
| 2 | ABBV |
AbbVie Inc.
|
341,851 | $86,023,385 | |
| 3 | JNJ |
Johnson & Johnson
|
308,337 | $78,308,347 | |
| 4 | MRK |
Merck & Co., Inc.
|
309,626 | $39,786,941 | |
| 5 | AMGN |
Amgen Inc
|
69,521 | $25,174,944 | |
| 6 | NVO |
Novo Nordisk A S
|
341,905 | $16,390,925 | |
| 7 | AZN |
Astrazeneca PLC
This page
|
84,701 | $16,061,003 | |
| 8 | PFE |
Pfizer Inc
|
209,637 | $5,048,058 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,061,003 | 84,701 | Shares | Defined | 2026-07-27 | |
| 2026-03-31 | $15,720,406 | 79,710 | Shares | Defined | 2026-05-05 | |
| No filing history on record for this holder in this stock. | ||||||